191 related articles for article (PubMed ID: 31032220)
21. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Wang L; Jiang Q; Hua S; Zhao M; Wu Q; Fu Q; Fang W; Guo S
Dis Markers; 2014; 2014():298795. PubMed ID: 24692842
[TBL] [Abstract][Full Text] [Related]
22. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
23. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH
Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265
[TBL] [Abstract][Full Text] [Related]
24. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
25. Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas.
Yang Y; Liang S; Li Y; Gao F; Zheng L; Tian S; Yang P; Li L
Oncol Lett; 2017 Dec; 14(6):7179-7184. PubMed ID: 29344149
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
Wang S; Fang W
Histopathology; 2011 Jan; 58(2):217-24. PubMed ID: 21255068
[TBL] [Abstract][Full Text] [Related]
27. PAK6 promotes cervical cancer progression through activation of the Wnt/β-catenin signaling pathway.
Yang Q; Zhao Y; Chen Y; Chang Y; Huang A; Xu T; Li G; Wu G
Oncol Lett; 2020 Sep; 20(3):2387-2395. PubMed ID: 32782556
[TBL] [Abstract][Full Text] [Related]
28. DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression.
Chen Y; Wang Q; Wang Q; Liu J; Jiang X; Zhang Y; Liu Y; Zhou F; Liu H
Front Pharmacol; 2018; 9():1558. PubMed ID: 30733679
[TBL] [Abstract][Full Text] [Related]
29. The expression and prognostic significance of hepatoma-derived growth factor in oral cancer.
Lin YW; Li CF; Chen HY; Yen CY; Lin LC; Huang CC; Huang HY; Wu PC; Chen CH; Chen SC; Tai MH
Oral Oncol; 2012 Jul; 48(7):629-35. PubMed ID: 22361040
[TBL] [Abstract][Full Text] [Related]
30. Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer.
Liu XJ; Liu WL; Yang FM; Yang XQ; Lu XF
Onco Targets Ther; 2015; 8():2101-9. PubMed ID: 26316779
[TBL] [Abstract][Full Text] [Related]
31. NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
Liu S; Zhang Y; Cui S; Song D; Li B; Chen Q; Yao G; Gong B
Cancer Cell Int; 2021 Nov; 21(1):605. PubMed ID: 34774047
[TBL] [Abstract][Full Text] [Related]
32. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
[TBL] [Abstract][Full Text] [Related]
33. The expression and clinical significance of HDGF in osteosarcoma.
Chen Z; Qiu S; Lu X
Onco Targets Ther; 2015; 8():2509-17. PubMed ID: 26392778
[TBL] [Abstract][Full Text] [Related]
34. TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway.
Song Y; Zhou G; Song E; Zhan L; Wang Q; Song H; Xia J; Cong L
Evid Based Complement Alternat Med; 2022; 2022():6235771. PubMed ID: 36387361
[TBL] [Abstract][Full Text] [Related]
35. Hepatoma-derived growth factor enhances osteoblastic transformation of rat aortic vascular smooth muscle cells in vitro.
Cheng CI; Chang HR; Tai MH; Chou MH; Chen GT; Chen PH; Kao YH
Life Sci; 2020 Sep; 256():117964. PubMed ID: 32534036
[TBL] [Abstract][Full Text] [Related]
36. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
[TBL] [Abstract][Full Text] [Related]
37. MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth factor.
Sun B; Gu X; Chen Z; Xiang J
Am J Cancer Res; 2015; 5(12):3635-44. PubMed ID: 26885452
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin C-Terminal Hydrolase L5 (UCHL5) Accelerates the Growth of Endometrial Cancer via Activating the Wnt/β-Catenin Signaling Pathway.
Liu D; Song Z; Wang X; Ouyang L
Front Oncol; 2020; 10():865. PubMed ID: 32596150
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
